Quality of Life Related to the Care of Women Living With HIV During the Perinatal Period

Condition(s) studied

Investigational drug(s) / intervention(s)

Questionary: Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum

Study summary

"The improvement of patient care by assessing the Quality of Life Related to Care (QLRC) in pregnant women living with HIV is of great importance for informing decision-making, resource allocation, and health policy formulation Prospective descriptive survey of women living with HIV followed for a pregnancy in the Infectious diseases department of Bichat-Claude Bernard Hospital, PARIS, France, between the first obstetric ultrasound and the 28th week of amenorrhea.

After recruitment during a follow-up consultation:

Information regarding the prenatal and perinatal management of HIV and the infant's outcomes up to 12 months will be collected retrospectively through the medical records.

Three self-questionnaires, either completed independently or with assistance, will be administered at inclusion (between the first obstetric ultrasound and 28 weeks of amenorrhea), during the third trimester of pregnancy, and at 1 year postpartum."

Eligibility

Primary outcome measure(s)

• Collection of perceptions of pregnancy care via the Hospital Anxiety and Depression Scale — during the Perinatal Period at 1 Year Postpartum

Trial sites (1)

More Assistance Publique - Hôpitaux de Paris trials in France

Other trials for the same condition